Jianping Guo

8.7k total citations · 2 hit papers
124 papers, 4.8k citations indexed

About

Jianping Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jianping Guo has authored 124 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 28 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Jianping Guo's work include Histone Deacetylase Inhibitors Research (14 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Ubiquitin and proteasome pathways (11 papers). Jianping Guo is often cited by papers focused on Histone Deacetylase Inhibitors Research (14 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Ubiquitin and proteasome pathways (11 papers). Jianping Guo collaborates with scholars based in China, United States and Japan. Jianping Guo's co-authors include Wenyi Wei, Jinfang Zhang, Xiangpeng Dai, Wenjian Gan, Pengda Liu, Ji Cheng, Brian J. North, Qiwei Jiang, Gordon J. Freeman and Xia Bu and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Jianping Guo

117 papers receiving 4.7k citations

Hit Papers

Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP... 2017 2026 2020 2023 2017 2024 200 400 600

Peers

Jianping Guo
Gong Yang China
Meng Qiao China
Benjamin D. Hopkins United States
Chunhong Yan United States
Kian‐Huat Lim United States
Jianping Guo
Citations per year, relative to Jianping Guo Jianping Guo (= 1×) peers Yangfu Jiang

Countries citing papers authored by Jianping Guo

Since Specialization
Citations

This map shows the geographic impact of Jianping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Guo more than expected).

Fields of papers citing papers by Jianping Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Guo. The network helps show where Jianping Guo may publish in the future.

Co-authorship network of co-authors of Jianping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Guo. A scholar is included among the top collaborators of Jianping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Guo. Jianping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Peipei, Qiwei Jiang, Xiaobo Wu, et al.. (2025). Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges. The Innovation. 6(8). 100918–100918.
2.
Wang, Xinxin, et al.. (2025). Recent advances in smart electrochemical sensors for detection of foodborne hazards. Trends in Food Science & Technology. 162. 105109–105109. 3 indexed citations
3.
Zhang, Yi, Yaqing Su, Xueji Wu, et al.. (2025). High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover. Gut. 74(10). 1711–1727. 1 indexed citations
4.
Jiang, Qiwei, Lang Bu, & Jianping Guo. (2025). Insights into palmitoylation-mediated regulation of inflammasomes. Trends in Immunology. 46(4). 266–269. 4 indexed citations
5.
Guo, Jianping, Yulan Wang, Huanhuan Zheng, et al.. (2024). Renal venous sampling assisted the diagnosis of juxtaglomerular cell tumor: a case report and literature review. Frontiers in Oncology. 13. 1298684–1298684.
6.
Stevens, Laura E., Filipa Lynce, Wendy Y. Chen, et al.. (2024). A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer. Cancer Research. 84(11). 1781–1798. 8 indexed citations
8.
Guo, Jianping, Zijian Deng, Longyang Jin, et al.. (2023). Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study. Journal of Cancer Research and Clinical Oncology. 149(20). 17881–17896. 2 indexed citations
9.
Ma, Xiaoxiao, Shuqin Jia, Min Liang, et al.. (2023). TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduction and Targeted Therapy. 8(1). 246–246. 51 indexed citations
10.
Guo, Jianping, Wuming Zhang, Xianqin Hu, et al.. (2022). A Six-microRNA Signature Nomogram for Preoperative Prediction of Tumor Deposits in Colorectal Cancer. SHILAP Revista de lepidopterología. 9 indexed citations
11.
Peng, Yunhua, Jing Liu, Zhen Wang, et al.. (2022). Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc. Cell Death and Differentiation. 29(9). 1730–1743. 30 indexed citations
12.
Su, Yaqing, et al.. (2022). Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis. Molecular Cancer Research. 20(9). 1339–1353. 31 indexed citations
14.
Qian, Guoqing, Jianping Guo, C. Hu, et al.. (2021). Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors. Molecular Cancer Research. 19(10). 1622–1634. 34 indexed citations
15.
Zhang, Lizhen, Liangmin Fu, Haohua Yao, et al.. (2021). Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. Oncogene. 40(37). 5639–5650. 28 indexed citations
16.
Guo, Jianping, Lei Wang, Xiaoyan Wang, et al.. (2020). Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy. Medicine. 99(49). e23321–e23321. 1 indexed citations
17.
Guo, Jianping, Ji Cheng, Brian J. North, & Wenyi Wei. (2017). Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(2). 341–358. 47 indexed citations
18.
Zhang, Jinfang, Kai Xu, Pengda Liu, et al.. (2016). Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Molecular Cell. 62(6). 929–942. 89 indexed citations
19.
Liu, Pengda, Wenjian Gan, Y. Rebecca Chin, et al.. (2015). PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex. Cancer Discovery. 5(11). 1194–1209. 307 indexed citations
20.
Guo, Wei, Jianping Guo, Andrea I. Doseff, et al.. (2004). Activated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model. The Journal of Immunology. 173(2). 1374–1379. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026